Prometheus Bio Appoints Mike Walther as Chief Commercial Officer

13:51 EDT 28 Oct 2019 | Xconomy

Mike Walther has been appointed chief commercial officer of Prometheus Biosciences, which is developing new gastroenterology and autoimmune disease drugs and diagnostics. Walther was most recently general manager at Aries Pharmaceuticals. His experience also includes a series of management roles, including vice president of commercial development, at NestlĂ© Health Science unit Prometheus Laboratories. The conglomerate’s […]

Original Article: Prometheus Bio Appoints Mike Walther as Chief Commercial Officer


More From BioPortfolio on "Prometheus Bio Appoints Mike Walther as Chief Commercial Officer"

Quick Search

Relevant Topics

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...